Carboplatin Injection recall: Particulate Matter
Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, NDC 61703-339-50 (Hospira…
Why was Carboplatin Injection recalled?
Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
lots Z011711AA (Hospira label) and Z011711AB (Novaplus label), Exp. 08/2013
- Product
- Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, NDC 61703-339-50 (Hospira…
- Recalling firm
- Hospira Inc.
- Quantity
- 31,326 vials
- Distribution
- Nationwide and Puerto Rico.
- Recall date
- February 13, 2013
- Classification
- Class I
- Status
- Completed
- Agency
- FDA (drug)